Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | BRI3 | Human | (+)-schisandrin B | multiple interactions | ISO | Bri3 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of BRI3 mRNA] | CTD | PMID:31150632 | BRI3 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Bri3 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of BRI3 mRNA | CTD | PMID:36331819 | BRI3 | Human | 1,2-dichloroethane | decreases expression | ISO | Bri3 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of BRI3 mRNA | CTD | PMID:28189721 and PMID:28960355 | BRI3 | Human | 1,2-dimethylhydrazine | decreases expression | ISO | Bri3 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of BRI3 mRNA | CTD | PMID:22206623 | BRI3 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Bri3 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BRI3 mRNA | CTD | PMID:22206623 | BRI3 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Norethindrone Acetate] results in increased expression of BRI3 mRNA | CTD | PMID:22217510 | BRI3 | Human | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of BRI3 mRNA | CTD | PMID:23019147 | BRI3 | Human | 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | affects splicing | EXP | | 6480464 | Metribolone affects the splicing of BRI3 mRNA | CTD | PMID:17010196 | BRI3 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Bri3 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BRI3 mRNA | CTD | PMID:18796159 and PMID:21215274 | BRI3 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Bri3 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of BRI3 mRNA | CTD | PMID:34747641 | BRI3 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Bri3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of BRI3 mRNA | CTD | PMID:21570461 | BRI3 | Human | 2-hydroxypropanoic acid | increases expression | EXP | | 6480464 | Lactic Acid results in increased expression of BRI3 mRNA | CTD | PMID:30851411 | BRI3 | Human | 4,4'-sulfonyldiphenol | decreases expression | ISO | Bri3 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of BRI3 mRNA | CTD | PMID:33297965 | BRI3 | Human | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of BRI3 mRNA | CTD | PMID:32763439 | BRI3 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of BRI3 intron | CTD | PMID:30157460 | BRI3 | Human | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of BRI3 mRNA | CTD | PMID:33167477 | BRI3 | Human | benzo[a]pyrene | increases expression | ISO | Bri3 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of BRI3 mRNA | CTD | PMID:22228805 | BRI3 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of BRI3 intron | CTD | PMID:30157460 | BRI3 | Human | benzo[e]pyrene | increases methylation | EXP | | 6480464 | benzo(e)pyrene results in increased methylation of BRI3 intron | CTD | PMID:30157460 | BRI3 | Human | bisphenol A | increases expression | ISO | Bri3 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of BRI3 mRNA | CTD | PMID:25181051 more ... | BRI3 | Human | bisphenol A | increases expression | ISO | Bri3 (Mus musculus) | 6480464 | bisphenol A results in increased expression of BRI3 mRNA | CTD | PMID:32156529 and PMID:38074096 | BRI3 | Human | bisphenol A | decreases expression | ISO | Bri3 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of BRI3 mRNA | CTD | PMID:30245210 | BRI3 | Human | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of BRI3 mRNA | CTD | PMID:30903817 | BRI3 | Human | carbon nanotube | decreases expression | ISO | Bri3 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 and PMID:25620056 | BRI3 | Human | chlordecone | increases expression | ISO | Bri3 (Mus musculus) | 6480464 | Chlordecone results in increased expression of BRI3 mRNA | CTD | PMID:33711761 | BRI3 | Human | chlorpyrifos | increases expression | ISO | Bri3 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of BRI3 mRNA | CTD | PMID:37019170 | BRI3 | Human | ciguatoxin CTX1B | affects expression | ISO | Bri3 (Mus musculus) | 6480464 | Ciguatoxins affects the expression of BRI3 mRNA | CTD | PMID:18353800 | BRI3 | Human | clofibrate | decreases expression | ISO | Bri3 (Mus musculus) | 6480464 | Clofibrate results in decreased expression of BRI3 mRNA | CTD | PMID:17585979 | BRI3 | Human | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of BRI3 mRNA | CTD | PMID:19549813 | BRI3 | Human | coumestrol | decreases expression | EXP | | 6480464 | Coumestrol results in decreased expression of BRI3 mRNA | CTD | PMID:19167446 | BRI3 | Human | cyclosporin A | decreases expression | ISO | Bri3 (Mus musculus) | 6480464 | Cyclosporine results in decreased expression of BRI3 mRNA | CTD | PMID:19770486 | BRI3 | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of BRI3 mRNA | CTD | PMID:25562108 | BRI3 | Human | diazinon | increases methylation | EXP | | 6480464 | Diazinon results in increased methylation of BRI3 gene | CTD | PMID:22964155 | BRI3 | Human | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of BRI3 mRNA | CTD | PMID:35967413 | BRI3 | Human | doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of BRI3 mRNA | CTD | PMID:29803840 | BRI3 | Human | epoxiconazole | affects expression | ISO | Bri3 (Mus musculus) | 6480464 | epoxiconazole affects the expression of BRI3 mRNA | CTD | PMID:35436446 | BRI3 | Human | ethanol | increases expression | ISO | Bri3 (Mus musculus) | 6480464 | Ethanol results in increased expression of BRI3 mRNA | CTD | PMID:30319688 | BRI3 | Human | fipronil | decreases expression | ISO | Bri3 (Rattus norvegicus) | 6480464 | fipronil results in decreased expression of BRI3 mRNA | CTD | PMID:23962444 | BRI3 | Human | fluoxetine | increases expression | EXP | | 6480464 | Fluoxetine results in increased expression of BRI3 mRNA | CTD | PMID:37386098 | BRI3 | Human | folic acid | multiple interactions | ISO | Bri3 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BRI3 mRNA | CTD | PMID:22206623 | BRI3 | Human | gentamycin | decreases expression | ISO | Bri3 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of BRI3 mRNA | CTD | PMID:22061828 | BRI3 | Human | gentamycin | increases expression | ISO | Bri3 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of BRI3 mRNA | CTD | PMID:33387578 | BRI3 | Human | hypochlorous acid | decreases expression | ISO | Bri3 (Mus musculus) | 6480464 | Hypochlorous Acid results in decreased expression of BRI3 mRNA | CTD | PMID:19376150 | BRI3 | Human | inulin | multiple interactions | ISO | Bri3 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of BRI3 mRNA | CTD | PMID:36331819 | BRI3 | Human | lead diacetate | decreases expression | ISO | Bri3 (Mus musculus) | 6480464 | lead acetate results in decreased expression of BRI3 mRNA | CTD | PMID:21829687 | BRI3 | Human | leflunomide | decreases expression | ISO | Bri3 (Mus musculus) | 6480464 | leflunomide results in decreased expression of BRI3 mRNA | CTD | PMID:19751817 | BRI3 | Human | methapyrilene | increases methylation | EXP | | 6480464 | Methapyrilene results in increased methylation of BRI3 intron | CTD | PMID:30157460 | BRI3 | Human | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of BRI3 mRNA | CTD | PMID:23649840 | BRI3 | Human | Monobutylphthalate | decreases expression | ISO | Bri3 (Mus musculus) | 6480464 | monobutyl phthalate results in decreased expression of BRI3 mRNA | CTD | PMID:35278568 | BRI3 | Human | N-nitrosodiethylamine | decreases expression | ISO | Bri3 (Rattus norvegicus) | 6480464 | Diethylnitrosamine results in decreased expression of BRI3 mRNA | CTD | PMID:19638242 | BRI3 | Human | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of BRI3 mRNA | CTD | PMID:29067470 | BRI3 | Human | paracetamol | increases expression | ISO | Bri3 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of BRI3 mRNA | CTD | PMID:33387578 | BRI3 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Bri3 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of BRI3 mRNA more ... | CTD | PMID:36331819 | BRI3 | Human | phenobarbital | increases expression | ISO | Bri3 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of BRI3 mRNA | CTD | PMID:19270015 | BRI3 | Human | propiconazole | decreases expression | ISO | Bri3 (Mus musculus) | 6480464 | propiconazole results in decreased expression of BRI3 mRNA | CTD | PMID:21278054 | BRI3 | Human | rac-lactic acid | increases expression | EXP | | 6480464 | Lactic Acid results in increased expression of BRI3 mRNA | CTD | PMID:30851411 | BRI3 | Human | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide analog results in increased expression of BRI3 mRNA | CTD | PMID:25895662 | BRI3 | Human | silicon dioxide | increases expression | ISO | Bri3 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of BRI3 mRNA | CTD | PMID:29203145 | BRI3 | Human | Soman | decreases expression | ISO | Bri3 (Rattus norvegicus) | 6480464 | Soman results in decreased expression of BRI3 mRNA | CTD | PMID:19281266 | BRI3 | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of BRI3 mRNA | CTD | PMID:31533062 | BRI3 | Human | temozolomide | decreases expression | EXP | | 6480464 | Temozolomide results in decreased expression of BRI3 mRNA | CTD | PMID:31758290 | BRI3 | Human | tetrachloromethane | multiple interactions | ISO | Bri3 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of BRI3 mRNA] | CTD | PMID:31150632 | BRI3 | Human | tetrachloromethane | decreases expression | ISO | Bri3 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in decreased expression of BRI3 mRNA | CTD | PMID:31150632 | BRI3 | Human | tungsten | increases expression | ISO | Bri3 (Mus musculus) | 6480464 | Tungsten results in increased expression of BRI3 mRNA | CTD | PMID:30912803 | BRI3 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of BRI3 mRNA | CTD | PMID:23179753 and PMID:28001369 | BRI3 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of BRI3 mRNA | CTD | PMID:25979313 | |